Moderna to Present at Upcoming Bernstein's 41st Annual Strategic Decisions Conference (SDC) on May 29, 2025
-
Beale to spearhead First Nations and Pasifika side against Lions
-
Wimbledon: England's garden Grand Slam
-
Matcha: the Japanese tea taking over the world
-
Inter Milan, Monterrey join Dortmund in Club World Cup last 16
-
Trail Blazers pick China's Yang in NBA draft first-round surprise
-
Global matcha 'obsession' drinks Japan tea farms dry
-
US judge sides with Meta in AI training copyright case
-
'Battle of Seattle' as Inter down nine-man River to advance
-
China hosts Iranian, Russian defence ministers against backdrop of 'momentous change'
-
Stocks down with eyes on Mideast, dollar hit by Trump Fed comment
-
Syrian architect uses drone footage to help rebuild hometown
-
Verstappen hoping upgrades can boost title defence at Red Bull home race
-
After 'Dune,' Denis Villeneuve to helm next James Bond film
-
Thailand makes new proposal to restrict cannabis sales
-
Ecuador's most-wanted gang leader 'Fito' captured
-
Tunisia U-turn on phosphate plant sparks anger in blighted city
-
Trial of Sean 'Diddy' Combs heads into closing arguments
-
Wallabies release Reds pair Faessler and Paisami for Lions clash
-
UN Charter: a founding document violated and ignored
-
Vinicius, Mbappe have to defend: Real Madrid's Alonso
-
US teen Cooper Flagg chosen by Mavericks with top pick in NBA draft
-
Guardiola says City must be ready to 'suffer' in Orlando heat
-
NBA studying uptick of Achilles injuries - Silver
-
TransGlobal Assets Inc. (OTC:TMSH) Officially Launches DateGuard, Its Flagship Emotional Compatibility Dating App
-
Pacquiao 'hungry' for comeback after four-year layoff
-
'Job done': Sundowns coach proud despite Club World Cup exit
-
RFK Jr vaccine panel targets childhood vaccinations in first meeting
-
Tech giants' net zero goals verging on fantasy: researchers
-
Australia quicks hit back after strong West Indies bowling effort
-
Dortmund through to Club World Cup last 16, Fluminense deny Sundowns
-
Judge orders Trump admin to release billions in EV charging funds
-
Sale of NBA's $10 bn Lakers expected to close this year
-
US Fed proposes easing key banking rule
-
Nvidia hits fresh record while global stocks are mixed
-
Elliott-inspired England to play Germany in Under-21 Euros final
-
Gunmen kill 11 in crime-hit Mexican city
-
Mbappe absent from Real Madrid squad for Salzburg Club World Cup clash
-
Sainz opts out of race for FIA presidency
-
Shamar Joseph rips through Australia top order in first Test
-
Court rejects EDF complaint over Czech nuclear tender
-
Mbappe returns to Real Madrid training at Club World Cup
-
Kenya anniversary protests turn violent, 8 dead
-
Elliott double fires England into Under-21 Euros final
-
Trans campaigners descend on UK parliament to protest 'bathroom ban'
-
New York mayoral vote floors Democratic establishment
-
Trump claims 'win' as NATO agrees massive spending hike
-
EU probes Mars takeover of Pringles maker Kellanova
-
Sidelined Zelensky still gets Trump face time at NATO summit
-
Mexico president threatens to sue over SpaceX rocket debris
-
Amazon tycoon Bezos arrives in Venice for lavish wedding
Moderna to Present at Upcoming Bernstein's 41st Annual Strategic Decisions Conference (SDC) on May 29, 2025
CAMBRIDGE, MA / ACCESS Newswire / May 8, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conference:
Bernstein's 41st Annual Strategic Decisions Conference (SDC), on Thursday, May 29th at 10:00am ET
A live webcast of each of these presentations will be available under "Events and Presentations" in the Investors section of the Moderna website.
A replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation.
About Moderna
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.
Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
A.Mahlangu--AMWN